vTv Therapeutics Inc. - Class A Common Stock, $0.01 par value per share (VTVT)

Historical Holders from Q3 2023 to Q3 2025

Symbol
VTVT on Nasdaq
CUSIP
918385204
Type / Class
Equity / Class A Common Stock, $0.01 par value per share
Shares outstanding
4.18M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
988K
Holdings value
$23.1M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
23
Number of buys
11
Number of sells
-4
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of vTv Therapeutics Inc. - Class A Common Stock, $0.01 par value per share (VTVT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Invus Global Management, LLC 9.4% -5.9% $9.18M $1.05M 393K +12.9% Raymond Debbane Sep 30, 2025
Samsara BioCapital, L.P. 9.9% 0% $5.15M 343K 0% Srinivas Akkaraju Sep 22, 2025
Trails Edge Capital Partners, LP 9.9% $5.11M 341K Trails Edge Capital Partners, LP Aug 29, 2025

Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, $0.01 par value per share (VTVT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 988K $23.1M +$9.36M $23.35 23
2025 Q2 587K $8.74M +$226K $15.00 21
2025 Q1 572K $9.9M +$353K $17.32 20
2024 Q4 551K $7.57M +$134K $13.80 17
2024 Q3 542K $7.34M +$2.52M $13.56 20
2024 Q2 348K $6.15M +$252K $17.66 19
2024 Q1 334K $7.85M +$6.24M $23.53 19
2023 Q4 68.6K $789K +$772K $11.50 14
2023 Q3 600 $287 +$287 $0.48 1